Positively Charged Combinatory Drug Delivery Systems against Multi-Drug-Resistant Breast Cancer: Beyond the Drug Combination-Reference-Cited by-同舟云学术

Positively Charged Combinatory Drug Delivery Systems against Multi-Drug-Resistant Breast Cancer: Beyond the Drug Combination

Published:2017-02-16 Issue:8 Volume:9 Page:6804-6815
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Yan Xu¹,Yu Qingsong¹^ORCID,Guo Linyi¹,Guo Wenxuan¹,Guan Shuli¹,Tang Hao¹,Lin Shanshan¹,Gan Zhihua¹

Affiliation:

1. The State Key Laboratory of Organic−inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, PR China

Funder

Ministry of Education of the People's Republic of China

China Postdoctoral Science Foundation

Ministry of Finance

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.6b14244

Reference61 articles.

1. A small molecule nanodrug consisting of amphiphilic targeting ligand–chemotherapy drug conjugate for targeted cancer therapy

2. Nanomedicine: current status and future prospects

3. Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway

4. Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities

5. Anti-Angiogenesis

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-based strategies for overcoming multidrug-resistance in cancer therapy;Chinese Chemical Letters;2024-03

2. pH-responsive star-shaped poly (ε-carprolactone)-co-poly maleic anhydride micelles for synergistic breast cancer combination chemotherapy;Reactive and Functional Polymers;2023-12

3. Current and future outlook of loaded components in hydrogel composites for the treatment of chronic diabetic ulcers;Frontiers in Bioengineering and Biotechnology;2023-02-13

4. Stimulus-responsive hybrid nanoparticles based on multiple lipids for the co-delivery of doxorubicin and Sphk2-siRNA and breast cancer therapy;Food and Chemical Toxicology;2023-01

5. Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma;Cancers;2022-09-07